who we are

Press

07/19/2022 - 10:14

HIPRA’s COVID-19 vaccine induces a good neutralising antibody response against the BA.2, BA.4 and BA.5 subvariants of Omicron

Human

05/18/2022 - 10:13

HIPRA initiates the first Phase III clinical trial of Covid-19 vaccine in immunocompromised people

Human

03/29/2022 - 14:02

EMA starts rolling review of Covid-19 HIPRA’s vaccine

Human

03/16/2022 - 08:45

GoodGut and Vall d'Hebron Barcelona Hospital are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome

Human

03/11/2022 - 10:00

AEMPS authorizes Phase IIb second clinical trial of the HIPRA’s vaccine against Covid-19

Human

02/01/2022 - 15:33

AEMPS authorizes phase III clinical trial of the HIPRA’s vaccine against Covid-19

Human